Literature DB >> 15096807

Arterial stiffness and endothelial dysfunction in HIV-infected children.

Damien Bonnet1, Yacine Aggoun, Isabelle Szezepanski, Nassima Bellal, Stéphane Blanche.   

Abstract

BACKGROUND: The role of antiretroviral therapy in acceleration of atherosclerosis in HIV-infected adults is controversial, partly because of the confounding effects of the involvement of classic cardiovascular risk factors.
OBJECTIVE: To study vascular function in HIV-infected children.
DESIGN: Cross-sectional study of 49 HIV-infected children (34 receiving antiretroviral therapy and 15 never treated) and if 24 age- and sex-matched controls.
METHODS: Automatic, computerized, ultrasonic procedure evaluation of geometric and mechanical properties of the common carotid artery, and of the endothelium-dependent dilation and endothelium-independent dilation.
RESULTS: Relative systolodiastolic variations in diameter of the carotid artery in HIV-infected children were significantly lower than those in controls, but there was no significant difference in intima-media thickness. Cross-sectional compliance and distensibility were also significantly lower. Wall stiffness, assessed as the incremental elastic modulus, was larger in HIV-infected children. Endothelium-dependent dilation was lower in HIV-infected children but non-endothelium-dependent dilation was similar to that in controls. We did not find differences for any of the vascular variables between HIV-infected children receiving antiretroviral therapy and those never treated. All arterial variables were similar in children with and without dyslipidemia.
CONCLUSIONS: HIV-infected children had a vascular dysfunction in the absence of cardiovascular risk factors. In this short series, no additional detrimental effects were observed after a mean of 5 years of antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096807     DOI: 10.1097/00002030-200404300-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  36 in total

1.  Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

Authors:  Tracie L Miller; Gabriel Somarriba; E John Orav; Armando J Mendez; Daniela Neri; Natasha Schaefer; Lourdes Forster; Ronald Goldberg; Gwendolyn B Scott; Steven E Lipshultz
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

2.  Association between human immunodeficiency virus infection and stiffness of the common carotid artery.

Authors:  Eric C Seaberg; Lorie Benning; A Richey Sharrett; Jason M Lazar; Howard N Hodis; Wendy J Mack; Mark J Siedner; John P Phair; Lawrence A Kingsley; Robert C Kaplan
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

3.  T cell activation predicts carotid artery stiffness among HIV-infected women.

Authors:  Robert C Kaplan; Elizabeth Sinclair; Alan L Landay; Nell Lurain; A Richey Sharrett; Stephen J Gange; Xiaonan Xue; Christina M Parrinello; Peter Hunt; Steven G Deeks; Howard N Hodis
Journal:  Atherosclerosis       Date:  2011-03-15       Impact factor: 5.162

4.  Cardiovascular and Endothelial Disease in HIV Infection.

Authors:  Michelle S Cespedes; Judith A Aberg
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

5.  Echocardiography and carotid intima-media thickness among asymptomatic HIV-infected adolescents in Thailand.

Authors:  Prakul Chanthong; Keswadee Lapphra; Supawan Saihongthong; Sirintip Sricharoenchai; Orasri Wittawatmongkol; Wanatpreeya Phongsamart; Supattra Rungmaitree; Nantaka Kongstan; Kulkanya Chokephaibulkit
Journal:  AIDS       Date:  2014-09-10       Impact factor: 4.177

6.  Arterial stiffness in HIV-infected youth and associations with HIV-related variables.

Authors:  Allison Ross Eckard; Paolo Raggi; Joshua H Ruff; Mary Ann O'Riordan; Julia C Rosebush; Danielle Labbato; Julie E Daniels; Monika Uribe-Leitz; Christopher T Longenecker; Grace A McComsey
Journal:  Virulence       Date:  2017-03-21       Impact factor: 5.882

7.  Azidothymidine (AZT) leads to arterial stiffening and intima-media thickening in mice.

Authors:  Laura Hansen; Ivana Parker; LaDeidra Monet Roberts; Roy L Sutliff; Manu O Platt; Rudolph L Gleason
Journal:  J Biomech       Date:  2013-04-25       Impact factor: 2.712

8.  Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.

Authors:  Erik R Kline; Dean J Kleinhenz; Bill Liang; Sergey Dikalov; David M Guidot; C Michael Hart; Dean P Jones; Roy L Sutliff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

9.  Arterial stiffness in the young: assessment, determinants, and implications.

Authors:  Yiu-Fai Cheung
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

Review 10.  Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.

Authors:  Erdembileg Anuurad; Alison Semrad; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-10       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.